Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2018
Pharma News, 2018
Torrey Pines Investment's i2020 Accelerator to Advance Snap Bio's Selective Kinase Inhibitor Platform for Treatment of Endodermal Cancers and Autoimmune Diseases
SAN DIEGO, Nov.
AbbVie's Mavyret shortens treatment period for some hep C patients
AbbVie’s hepatitis C blockbuster Mavyret could soon also be an eight-week treatment for patients with compensated cirrhosis, thanks to positive new phase 3b data.
Repeat violations stack up at Dr. Reddy's cancer drug plant
Management at Dr.
EMA recommends fexinidazole, the first all-oral treatment for sleeping sickness
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion of fexinidazole, the first all-oral treatment that has been ...
Pets can double as asthma antidote
(HealthDay)—The "hygiene hypothesis" holds that early exposure to a variety of microorganisms may decrease the risk for chronic inflammatory diseases, like asthma.
Chinese pharmaceutical companies boost exports to U.S.
LOS ANGELES, Nov.
Hungary becomes one of world's top 20 pharmaceutical exporters: minister
BUDAPEST, Nov.
Tens of thousands die in Africa each year due to fake drugs
DAKAR (Reuters) - When Moustapha Dieng came down with stomach pains one day last month he did the sensible thing and went to a doctor in his hometown of Ouagadougou, Burkina Faso’s capital.
Hope for Parkinson's patients as scientists discover how to destroy and prevent the build-up of toxic clumps in their brains
A new weapon has been discovered in the fight against Parkinson's disease after scientists worked out a way to get rid of toxic clumps of protein in the brain.
EISAI launches Lenvima in China
In addition to China, LENVIMA is approved for use in the treatment of HCC in Japan, the United States, Europe, and other countries in Asia and around the worldJapan's Eisai announced that its Chin...
Theragen agrees to transfer technology to J2H
Theragen ETEX said it has signed a technology transfer agreement related to TEJ-1704, an orally administrable derivative candidate for Radicut Injection, a Lou Gehrig's Disease treatment, with J2H...
German health minister calls for faster adoption of biosimilar drugs
FRANKFURT (Reuters) - Germany’s health minister Jens Spahn has called for faster adoption of cheaper copies of biotech drugs to treat cancer and autoimmune diseases to reign in rising public...
5
6
7
8
9
10
11
12
13
